Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 4876-4881

  Kim, Kwang S ^a,b   Lee, Hong J ^a,b   Jeong, Han S ^b,c   Li, Jianxue ^d   Teng, Yang D ^e   Sidman, Richard L ^d   Snyder, Evan Y ^f   Kim, Seung U ^a,b  

^a Chung Ang University College of Medicine   (South Korea)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Chonnam National University Medical School   (South Korea)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f BURNHAM INSTITUTE   (United States)

Author keywords

Hemorrhage; Multipotence; Stem cells; Stroke

Indexed keywords

TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; CELL CLONE; CELL DIFFERENTIATION; CELL EXPANSION; CELL RENEWAL; CELL SURVIVAL; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENGRAFTMENT; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN CELL; INDUCED CONDITIONAL SELF RENEWING PROGENITOR CELL; KARYOTYPE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NERVOUS SYSTEM INJURY; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; RAT; SAFETY; SOMATIC CELL; STEM CELL; TRANSCRIPTION INITIATION; TRANSLATION INITIATION;

ANIMALS; BRAIN; BRAIN INJURIES; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; NEURAL STEM CELLS; ONCOGENE PROTEIN P55(V-MYC); RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

RATTUS;

EID: 79953181303     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019743108     Document Type: Article

References (24)

1. Yamanaka S, Blau HM (2010) Nuclear reprogramming to a pluripotent state by three approaches. Nature 465:704-712.
2. Hanna JH, Saha K, Jaenisch R (2010) Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell 143:508-525.
3. Zaehres H, Kim JB, Schöler HR (2010) Induced pluripotent stem cells. Methods Enzymol 476:309-325.
4. Nakagawa M, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
5. Wernig M, Meissner A, Cassady JP, Jaenisch R (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10-12.
6. Meissner A, Wernig M, Jaenisch R (2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25:1177-1181. (Pubitemid 47538112)
7. Park IH, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
8. Singh AM, Dalton S (2009) The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5:141-149.
9. Snyder EY, et al. (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51.
10. Flax JD, et al. (1998) Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16:1033-1039. (Pubitemid 28515895)
11. Jeong S-W, et al. (2003) Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34:2258-2263. (Pubitemid 37099846)
12. Imitola J, et al. (2004) Inflammation's other face: Directed migration of human and mouse neural stem cells to site of CNS injury by the SDF1a/CXCR4-dependent pathway. Proc Natl Acad Sci USA 101:18117-18122. (Pubitemid 40054083)
13. Kim SK, et al. (2006) Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12:5550-5556.
14. Lee J-P, et al. (2007) Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med 13:439-447. (Pubitemid 46559825)
15. Redmond DE, Jr., et al. (2007) Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 104:12175-12180.
16. Lee HJ, Lim IJ, Lee MC, Kim SU (2010) Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res 88:3282-3294.
17. Knoepfler PS, Cheng PF, Eisenman RN (2002) N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16:2699-2712.
18. Cartwright P, et al. (2005) LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132:885-896. (Pubitemid 40484924)
19. Knoepfler PS (2008) Why myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell 2:18-21.
20. Dominguez-Sola D, et al. (2007) Non-transcriptional control of DNA replication by c-Myc. Nature 448:445-451. (Pubitemid 47123512)
21. Knoepfler PS, et al. (2006) Myc influences global chromatin structure. EMBO J 25: 2723-2734. (Pubitemid 43980380)
22. Oberst C, Hartl M, Weiskirchen R, Bister K (1999) Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele. Virology 253:193-207. (Pubitemid 29393305)
23. Singec I, et al. (2006) Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods 3:801-806. (Pubitemid 44445827)
24. Roy NS, et al. (2006) Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259-1268. (Pubitemid 44706928)